Bayer Cropscience Limited (NSE:BAYERCROP) — Market Cap & Net Worth

$2.32 Billion USD  · Rs214.11 Billion INR  · Rank #5724

Market Cap & Net Worth: Bayer Cropscience Limited (BAYERCROP)

Bayer Cropscience Limited (NSE:BAYERCROP) has a market capitalization of $2.32 Billion (Rs214.11 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #5724 globally and #248 in its home market, demonstrating a -0.50% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bayer Cropscience Limited's stock price Rs4764.10 by its total outstanding shares 44942092 (44.94 Million). Analyse BAYERCROP cash generation efficiency to see how efficiently the company converts income to cash.

Bayer Cropscience Limited Market Cap History: 2015 to 2026

Bayer Cropscience Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.46 Billion to $2.32 Billion (3.62% CAGR).

Index Memberships

Bayer Cropscience Limited is a constituent of 4 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NIFTY 500
NIFTY500
$3.11 Trillion 0.07% #228 of 500
NIFTY MIDCAP 150
NIFTYMIDCAP150
$695.80 Billion 0.33% #105 of 150
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
$1.11 Trillion 0.21% #140 of 400
NIFTY TOTAL MARKET
NIFTYTOTALMKT
$3.20 Trillion 0.07% #221 of 750

Weight: Bayer Cropscience Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Bayer Cropscience Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Bayer Cropscience Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.04x

Bayer Cropscience Limited's market cap is 0.04 times its annual revenue

Industry average: 0.07x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.39x

Bayer Cropscience Limited's market cap is 0.39 times its annual earnings

Industry average: 7.30x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $1.80 Billion $27.84 Billion $3.15 Billion 0.06x 0.57x
2017 $1.91 Billion $28.15 Billion $2.91 Billion 0.07x 0.66x
2018 $1.80 Billion $27.17 Billion $3.00 Billion 0.07x 0.60x
2019 $1.53 Billion $31.75 Billion $3.37 Billion 0.05x 0.45x
2020 $2.39 Billion $36.09 Billion $4.75 Billion 0.07x 0.50x
2021 $2.24 Billion $42.61 Billion $4.93 Billion 0.05x 0.46x
2022 $2.29 Billion $47.34 Billion $6.45 Billion 0.05x 0.36x
2023 $2.64 Billion $51.40 Billion $7.58 Billion 0.05x 0.35x
2024 $2.70 Billion $51.06 Billion $7.41 Billion 0.05x 0.36x
2025 $2.22 Billion $54.73 Billion $5.68 Billion 0.04x 0.39x

Competitor Companies of BAYERCROP by Market Capitalization

Companies near Bayer Cropscience Limited in the global market cap rankings as of May 4, 2026.

Key companies related to Bayer Cropscience Limited by market ranking:

  • Corteva Inc (NYSE:CTVA): Ranked #487 globally with a market cap of $53.89 Billion USD.
  • Nutrien Ltd (TO:NTR): Ranked #742 globally with a market cap of $35.75 Billion USD ( CA$49.42 Billion CAD).
  • Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #868 globally with a market cap of $30.42 Billion USD ( CN¥207.91 Billion CNY).
  • CF Industries Holdings Inc (NYSE:CF): Ranked #1580 globally with a market cap of $15.33 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#487 Corteva Inc NYSE:CTVA $53.89 Billion $80.85
#742 Nutrien Ltd TO:NTR $35.75 Billion CA$102.24
#868 Qinghai Salt Lake Industry Co.Ltd SHE:000792 $30.42 Billion CN¥39.29
#1580 CF Industries Holdings Inc NYSE:CF $15.33 Billion $122.69

Bayer Cropscience Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Bayer Cropscience Limited's market cap moved from $1.46 Billion to $ 2.32 Billion, with a yearly change of 3.62%.

Year Market Cap Change (%)
2026 Rs2.32 Billion +4.52%
2025 Rs2.22 Billion -17.89%
2024 Rs2.70 Billion +2.07%
2023 Rs2.64 Billion +15.36%
2022 Rs2.29 Billion +2.10%
2021 Rs2.24 Billion -5.96%
2020 Rs2.39 Billion +55.81%
2019 Rs1.53 Billion -15.11%
2018 Rs1.80 Billion -5.53%
2017 Rs1.91 Billion +6.30%
2016 Rs1.80 Billion +23.28%
2015 Rs1.46 Billion --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of Bayer Cropscience Limited was reported to be:

Source Market Cap
Yahoo Finance $2.32 Billion USD
MoneyControl $2.32 Billion USD
MarketWatch $2.32 Billion USD
marketcap.company $2.32 Billion USD
Reuters $2.32 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Bayer Cropscience Limited

NSE:BAYERCROP India Agricultural Inputs
Market Cap
$2.32 Billion
Rs214.11 Billion INR
Market Cap Rank
#5724 Global
#248 in India
Share Price
Rs4764.10
Change (1 day)
+1.71%
52-Week Range
Rs4289.70 - Rs6482.50
All Time High
Rs6836.59
About

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance… Read more